Inventor · disambiguated record
John Steven Garrett
Also filed as: GARRETT JOHN S · GARRETT JOHN STEVEN
7 granted patents·5 pending applications·491 citations·filing 1983–2016
89Inventor score
Top patents by PatentIndex Score
12 records- 0198US6773714B2Polymeric delivery formulations of leuprolide with improved efficacyATRIX LAB INC·Filed 2003·Granted Aug 10, 2004·224 cites·47 claims
- 0298US6565874B1Polymeric delivery formulations of leuprolide with improved efficacyATRIX LAB INC·Filed 2000·Granted May 20, 2003·214 cites·49 claims
- 0395US8486455B2Polymeric delivery formulations of leuprolide with improved efficacyDUNN RICHARD L·Filed 2010·Granted Jul 16, 2013·25 cites·5 claims
- 0486US9254307B2Polymeric delivery formulations of leuprolide with improved efficacyDUNN RICHARD L·Filed 2010·Granted Feb 9, 2016·6 cites·3 claims
- 0579US9504661B2Dapsone to treat rosaceaALLERGAN INC·Filed 2013·Granted Nov 29, 2016·3 cites·12 claims
- 0677US8586010B2Dapsone to treat rosasceaGARRETT JOHN S·Filed 2008·Granted Nov 19, 2013·3 cites·12 claims
- 0761US2007104759A1Polymeric delivery formulations of leuprolide with improved efficacyQLT USA INC·Filed 2006·Application pending·0 cites
- 0859US2004229912A1Polymeric delivery formulations of leuprolide with improved efficacyATRIX LAB INC·Filed 2004·Application pending·0 cites
- 0958US2016106805A1Polymeric delivery formulations of leuprolide with improved efficacyTOLMAR THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1056US2015150937A1Polymeric delivery formulations of leuprolide with improved efficacyTOLMAR THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1151US2017071882A1Dapsone to treat rosaceaALLERGAN INC·Filed 2016·Application pending·0 cites
- 1249US4476984AStorage rackGARRETT JOHN S·Filed 1983·Granted Oct 16, 1984·16 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when John Steven Garrett files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →